Clinical Trials
Rare Disease
Global
Sickle Cell Clinical Trial Education - Multi-State & UK Trial
Timeline
1 Year
Service Area
Events
Region
Global
This engagement was designed to establish a comprehensive framework for patient engagement and clinical trial educational meetings across priority markets in the United States and the United Kingdom.
Results
100+
Patients attended education congress
1:1
Onsite discussions
2
Global priority regions
The Challenge
The client was facing significant difficulty enrolling patients in their Sickle Cell Disease clinical trials. This recruitment hurdle was largely driven by existing stigmas and a lack of trust stemming from historical issues within Black communities.
Our Approach
Based on comprehensive advocacy landscape assessments, we implemented a framework for Community Patient Engagement Meetings (PEM) across U.S. and UK priority markets to address historical mistrust in Black communities. Key pillars of the approach included:
Community-Centric Engagement
We collaborated closely with state chapters of the National Sickle Cell Disease Association of America, Key Opinion Leaders (KOLs), and trial Principal Investigators to establish direct, trusted connections.
Compliant Educational Materials
To combat stigma and build trust, we designed highly patient-friendly information and materials that promoted enrollment and retention while remaining strictly compliant with the ABPI Code.
Educational Congress Hosting
We organized a dedicated clinical trial education congress hosted by stakeholders and KOLs in conjunction with the Principal Investigator to directly engage the patient community in an open forum.
The Outcome
The targeted, community-centric approach effectively built trust and resulted in a highly successful clinical trial recruitment effort. Key milestones included:
High Event Attendance
Over 100 patients attended the clinical trial education congress, where the compliant program and educational materials were shared directly with the community.
Direct Patient Support
The initiative successfully facilitated 1:1 onsite discussions with Trial Coordinators, allowing patients to get answers, reinforcing education, and further encouraging enrollment.
Dramatic Enrollment Increase
The comprehensive community engagement strategy led to a dramatic increase in clinical trial enrollment, backed by impressive feedback from supporting stakeholders.
